Passing the Storch: BMS takes on new director
This article was originally published in Scrip
Bristol-Myers Squibb has appointed Gerald Storch to its board of directors, joining the company's audit committee and the compensation and management development committee. Mr Storch is currently chair and CEO of global toy retailer Toys 'R' Us, and has previously served for companies such as Target and McKinsey & Company.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.